157 related articles for article (PubMed ID: 26392100)
1. Omega-3 Fatty Acids for Aromatase Inhibitor-Induced Musculoskeletal Pain: Anything Other Than a Placebo Effect?
Gianni L; Arcangeli V; Tamburini E; Tassinari D
J Clin Oncol; 2015 Dec; 33(36):4311-2. PubMed ID: 26392100
[No Abstract] [Full Text] [Related]
2. The Power of the Placebo in Symptom Management.
Henry NL; Griggs JJ
J Clin Oncol; 2015 Jun; 33(17):1870-2. PubMed ID: 25940722
[No Abstract] [Full Text] [Related]
3. Reply to L. Gianni et al.
Hershman DL; Unger JM
J Clin Oncol; 2015 Dec; 33(36):4312. PubMed ID: 26392106
[No Abstract] [Full Text] [Related]
4. Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.
Hershman DL; Unger JM; Crew KD; Awad D; Dakhil SR; Gralow J; Greenlee H; Lew DL; Minasian LM; Till C; Wade JL; Meyskens FL; Moinpour CM
J Clin Oncol; 2015 Jun; 33(17):1910-7. PubMed ID: 25940724
[TBL] [Abstract][Full Text] [Related]
5. Aromatase inhibitors and arthralgia: a growing pain?
Murphy C; Hudis CA; Dickler MN
Oncology (Williston Park); 2008 Nov; 22(12):1424, 1426. PubMed ID: 19322950
[No Abstract] [Full Text] [Related]
6. Improving tolerance of AIs: predicting risk and uncovering mechanisms of musculoskeletal toxicity.
Gold JM; Burstein HJ
Oncology (Williston Park); 2008 Nov; 22(12):1416, 1424. PubMed ID: 19322949
[No Abstract] [Full Text] [Related]
7. A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study.
Martínez N; Herrera M; Frías L; Provencio M; Pérez-Carrión R; Díaz V; Morse M; Crespo MC
Clin Transl Oncol; 2019 Apr; 21(4):489-498. PubMed ID: 30293230
[TBL] [Abstract][Full Text] [Related]
8. Effect of Tart Cherry on Aromatase Inhibitor-Induced Arthralgia (AIA) in Nonmetastatic Hormone-Positive Breast Cancer Patients: A Randomized Double-Blind Placebo-Controlled Trial.
Shenouda M; Copley R; Pacioles T; Lebowicz Y; Jamil M; Akpanudo S; Tirona MT
Clin Breast Cancer; 2022 Jan; 22(1):e30-e36. PubMed ID: 34275765
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).
Shen S; Unger JM; Crew KD; Till C; Greenlee H; Gralow J; Dakhil SR; Minasian LM; Wade JL; Fisch MJ; Henry NL; Hershman DL
Breast Cancer Res Treat; 2018 Dec; 172(3):603-610. PubMed ID: 30159789
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102.
Cathcart-Rake E; Novotny P; Leon-Ferre R; Le-Rademacher J; Storrick EM; Adjei AA; Terstriep S; Glaser R; Giuliano A; Mitchell WR; Page S; Austin C; Deming RL; Ferreira MA; Lafky JM; Birrell SN; Loprinzi CL
Support Care Cancer; 2021 Jan; 29(1):387-396. PubMed ID: 32372176
[TBL] [Abstract][Full Text] [Related]
11. Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain.
Lustberg MB; Orchard TS; Reinbolt R; Andridge R; Pan X; Belury M; Cole R; Logan A; Layman R; Ramaswamy B; Wesolowski R; Berger M; Patterson E; Loprinzi C; Shapiro CL; Yee L
Breast Cancer Res Treat; 2018 Feb; 167(3):709-718. PubMed ID: 29101597
[TBL] [Abstract][Full Text] [Related]
12. Effects of the Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: A randomized, controlled clinical trial.
Peng N; Yu M; Yang G; Fu Q; Xu Y; Yu J; Liu Q; Li C; Xu W; Zhang Y; Ma C; Yang L; Yu R; Wang X
Breast; 2018 Feb; 37():18-27. PubMed ID: 29059538
[TBL] [Abstract][Full Text] [Related]
13. Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management.
Gaillard S; Stearns V
Breast Cancer Res; 2011 Mar; 13(2):205. PubMed ID: 21457526
[TBL] [Abstract][Full Text] [Related]
14. Aromatase inhibitor-associated arthralgia syndrome.
Burstein HJ
Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic options for aromatase inhibitor-associated arthralgia in breast cancer survivors: A systematic review of systematic reviews, evidence mapping, and network meta-analysis.
Kim TH; Kang JW; Lee TH
Maturitas; 2018 Dec; 118():29-37. PubMed ID: 30415752
[TBL] [Abstract][Full Text] [Related]
16. Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management.
Henry NL; Giles JT; Stearns V
Oncology (Williston Park); 2008 Nov; 22(12):1401-8. PubMed ID: 19086600
[TBL] [Abstract][Full Text] [Related]
17. Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
Lintermans A; Vanderschueren D; Verhaeghe J; Van Asten K; Jans I; Van Herck E; Laenen A; Paridaens R; Billen J; Pauwels S; Vermeersch P; Wildiers H; Christiaens MR; Neven P
Eur J Cancer; 2014 Nov; 50(17):2925-31. PubMed ID: 25304297
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor-Associated Musculoskeletal Symptoms.
Henry NL; Unger JM; Till C; Crew KD; Fisch MJ; Hershman DL
JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34901744
[TBL] [Abstract][Full Text] [Related]
19. Dietary fatty acids for the treatment of OA, including fish oil.
Felson DT; Bischoff-Ferrari HA
Ann Rheum Dis; 2016 Jan; 75(1):1-2. PubMed ID: 26582822
[No Abstract] [Full Text] [Related]
20. Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients.
Lintermans A; Van Asten K; Jongen L; Van Brussel T; Laenen A; Verhaeghe J; Vanderschueren D; Lambrechts D; Neven P
Eur J Cancer; 2016 Mar; 56():31-36. PubMed ID: 26798969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
